Last year, Universe Pharmaceuticals Inc generated 13.26M USD for its biggest-performing segment, Sales of TCMD products. The China (Mainland) made the largest contribution, accounting for 17.86M USD last year.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Sales of TCMD products

Sales of third-party products

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Sales of TCMD products

13.26M(74.25%)

14.03M(60.92%)

18.57M(57.48%)

23.99M(59.76%)

29.56M(61.60%)

18.37M(59.84%)

20.90M(62.88%)

17.62M(61.80%)

Sales of third-party products

4.60M(25.75%)

9.00M(39.08%)

13.74M(42.52%)

16.15M(40.24%)

18.42M(38.40%)

12.33M(40.16%)

12.33M(37.12%)

10.89M(38.20%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

China (Mainland)

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

China (Mainland)

17.86M(100.00%)

23.02M(100.00%)

32.31M(100.00%)

40.14M(100.00%)

47.98M(100.00%)

30.70M(100.00%)

33.23M(100.00%)

28.51M(100.00%)